Key Pharmacy Recalls Cyanocobalamin Injections Due to Sterility Concerns
Key Pharmacy and Compounding Center is recalling specific lots of Cyanocobalamin injections because the firm cannot ensure the products are sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of infection or serious injury, meeting the criteria for a Severe rating.
Plain-English summary
Key Pharmacy and Compounding Center is recalling Cyanocobalamin 10mL Multiple Dose Vials (1mg/mL) prepared by the firm. The recall affects 2 vials per lot, specifically Lot # t02-13-2017@99 with an expiration date of 5/15/2017. These prescription-only injections were distributed nationwide in the U.S.A., as well as in Australia and Canada.
The recall was initiated due to a lack of assurance of sterility. The firm is recalling sterile compounded drugs within their expiry date because it cannot guarantee that the products remain sterile. This classification is designated as Class II by the FDA.
Consumers and healthcare providers should stop using the affected product immediately. Patients who have received this medication should consult their healthcare provider for guidance. The recall is limited to the specific lot number and expiration date listed above.
The recalled product
- Product
- CYANOCOBALAMIN 10ML MDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy
- Manufacturer
- Key Pharmacy and Compounding Center
- Category
- Drug — Compounded Injectable
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # t02-13-2017@99
- Exp 5/15/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Key Pharmacy and Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Key Pharmacy and Compounding Center
See all →- SevereKey Pharmacy Recalls Pyridoxal-5-Phosphate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Sterile Compounded Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighKey Pharmacy Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls 5-MTHF Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29